Philippe B. Pierrillas

Model-Based Adaptive Optimal Design (MBAOD) Improves Combination Dose Finding Designs: an Example in Oncology

Philippe B. Pierrillas, Sylvain Fouliard, Marylore Chenel et al. · The AAPS Journal · 2018 · 17 citations · Full text

Medicine, Oncology, Pharmacology +17

Modeling of Parkinson’s Disease Progression and Implications for Detection of Disease Modification in Treatment Trials

Benjamin Ribba, Tanya Simuni, Kenneth Marek et al. · Journal of Parkinson s Disease · 2024 · 15 citations · Full text

Medicine, Neurology, Neuroscience +17

Comparison of the Static <i>In Vivo</i> Approach to a Physiologically Based Pharmacokinetic Approach for Metabolic Drug–Drug Interactions Prediction

Michel Tod, Philippe B. Pierrillas, Laurent Bourguignon et al. · International Journal of Pharmacokinetics · 2016 · 14 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

Population PK and Semimechanistic PK/PD Modeling and Simulation of Relugolix Effects on Testosterone Suppression in Men with Prostate Cancer

T.Y. Lee, Philippe B. Pierrillas, Yu‐Wei Lin et al. · Clinical Pharmacology & Therapeutics · 2022 · 14 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Population pharmacokinetics of mobocertinib in healthy volunteers and patients with non–small cell lung cancer

Neeraj Gupta, Philippe B. Pierrillas, Michael J. Hanley et al. · CPT Pharmacometrics & Systems Pharmacology · 2022 · 11 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +8